Should term infants with a history of neonatal meningitis undergo a Hammersmith Infant Neurological Examination (HINE), and if so, at what age should it be performed?

HINE Testing in Term Infants with Neonatal Meningitis

Yes, term infants with a history of neonatal meningitis should undergo HINE testing, with initial assessment at 3 months of age and serial follow-up at 6,9, and 12 months.

Rationale for Testing

Neonatal meningitis represents a significant neurological insult to the developing brain, placing these infants in a high-risk category for cerebral palsy (CP) and other neurodevelopmental impairments. The 2017 JAMA Pediatrics guidelines explicitly recommend that infants admitted to the NICU—which includes those with neonatal meningitis—should receive early standardized assessments for CP detection 1. This strong recommendation is based on high-quality evidence prioritizing early intervention to optimize neuroplasticity and prevent secondary complications.

Testing Timeline and Interpretation

At 3 Months (Corrected Age)

• Perform initial HINE assessment
• HINE scores <57 are 96% predictive of CP 1
• This represents a strong recommendation based on moderate-quality evidence
• Early detection at this age enables access to critical early intervention during peak neuroplasticity

At 6,9, and 12 Months

• Serial HINE assessments are essential for ongoing risk stratification
• HINE scores <73 indicate high risk of CP 1
• HINE scores <40 almost always indicate CP 1
• The HINE demonstrates 90% predictive accuracy for CP at these ages 1

Clinical Decision Algorithm

For infants with neonatal meningitis history:

1. Schedule HINE at 3 months as the initial screening point

   • Score ≥57: Continue surveillance with repeat HINE at 6 months
   • Score <57: High risk—immediate referral to CP-specific early intervention

2. At 6,9, or 12 months:

   • Score ≥73: Lower risk, continue monitoring
   • Score 40-72: High risk of CP—refer to early intervention and consider MRI
   • Score <40: Almost certain CP—immediate comprehensive intervention

3. Combine HINE with:

   • MRI when feasible (80-90% predictive of CP) 1
   • Clinical observation for red flags: inability to sit by 9 months, hand asymmetry, inability to bear weight on feet 1

Why This Matters for Morbidity and Mortality

The evidence strongly supports that early detection enables early intervention during critical periods of brain plasticity, directly impacting long-term motor and cognitive outcomes 1. Recent research confirms HINE's utility extends beyond CP prediction to identifying cognitive delays at 2 years 2, making it particularly valuable for meningitis survivors who face multifaceted neurodevelopmental risks.

Important Caveats

• Normal HINE scores do not eliminate risk entirely—continue developmental surveillance through age 2 years
• HINE should be part of a comprehensive assessment, not used in isolation
• The examination requires trained examiners for reliability 3
• Consider that motor patterns evolve during the first 2 years; serial assessments are more informative than single time points 1

The combination of standardized neurological assessment (HINE), neuroimaging (MRI), and standardized motor assessment represents the most accurate approach for infants older than 5 months with detectable risks 1. However, when MRI is not immediately available or safe, HINE alone remains a strong screening tool with 90% predictive accuracy 1.